Sanara Medtech Inc. · NASDAQ:SMTI
Sanara Medtech — FY2021 Earnings Presentation
7 slides from Sanara Medtech's earnings presentation, Mar 30, 2022
Slide 1: Q4 and Full Year 2021 Earnings and Business Update Call
Q4 and Full Year 2021 Earnings and Business Update Call MedTech Evidence Based Healing ° e ° e e . . ° : ° e e ° ° - , ee e e 2e« @ ° 5 . e ee e@ e © 8 *¢ © @ ww « « «© © *®
Slide 2: Disclaimers
Disclaimers This presentation contains forward-looking statements that discuss expectations as to future trends, plans, events, results of operations or financial condition, or state other information relating to Sanara MedTech Inc. (the “Company,” “Sanara,” “we,” “our” or “us”). All statements othe
Slide 3: Commentary on Q4 and Full-Year 2021
Sanara MedTech Commentary on Q4 and Full-Year 2021 ¢ Financial Update + Highest sales quarter ($7.0 million) and full year ($24.1 million) in the Company’s history + Net loss of $3.6 million for Q4 and $8.0 million for the full year + Net loss impacted by increased SG&A, higher R&D costs, and losses
Slide 4: Surgical Products
Surgical Products Surgical Overview * 30 field sales managers (7 territory sales managers (“TSM”)) * Going forward we will continue to increase the proportion of TSMs to regional sales managers (“RSM”) in our sales force (TSMs receive a lower salary compared to RSMs) CellerateRX Surgical sold in 471
Slide 5: Additional Q4 Highlights
Additional Q4 Highlights Products + Launched two new innovative extracellular matrix products + FORTIFY TRG™ Tissue Repair Graft + FORTIFY FLOWABLE™ Extracellular Matrix + First sales of FORTIFY TRG™ Tissue Repair Graft in Q4 WounDerm + Continue to have discussions with a number of value-based and a
Slide 6: Full Year 2021 Financial Highlights
Full Year 2021 Financial Highlights Overview + Revenue + Generated revenues of $24.1 million compared to $15.6 million for the year ended December 31, 2020, a 55% increase from the prior year. * The higher revenues in 2021 were primarily due to increased sales of surgical wound care products as we c
Slide 7: Questions
Questions « Sanara E MedTech Evidence Based Healing